EVIDENCE MULTI STAT
DEAD

Serial Number

77360760

Owner

Randox Laboratories Limited

Attorney

Richard J. Groos

Filing Date

Dec 28, 2007

Add to watchlist:

No watchlists yet
View on USPTO

EVIDENCE MULTI STAT Trademark

Serial Number: 77360760 • Registration: 3751052

EVIDENCE MULTI STAT is a trademark filed by Randox Laboratories Limited on December 28, 2007. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics). The application is currently no longer active.

Owner Contact Info

Randox Laboratories Limited (18 trademarks)

Ardmore
Co. Antrim , GB

Entity Type: 99

Trademark Details

Filing Date

December 28, 2007

Registration Date

February 23, 2010

Published for Opposition

December 8, 2009

Cancellation Date

September 30, 2016

Goods & Services

Computer software for use in conjunction with in vitro diagnostic testing apparatus, namely, software to control sample processing, sample result reporting and test apparatus system robotics; computer hardware; computer programs for use in conjunction with in vitro diagnostic testing apparatus to control sample processing and sample result reporting; computer systems for use in conjunction with in vitro diagnostic testing apparatus to control sample processing and sample result reporting; computer systems for use in conjunction with in vitro diagnostic testing apparatus; downloadable computer databases and computer databases recorded on computer media for use in connection with in vitro diagnostic testing apparatus; scientific and optical apparatus and instruments, namely, a benchtop analytical system composed of barcode scanner and associated software, a chemiluminescent detection system, a temperature controlled incubator, and a reagent and patient sample dispenser, suitable for protein and DNA arrays for or relating to the analysis, monitoring, research and/or reporting of clinical data, for use in in vitro diagnostic testing procedures; medical apparatus and instruments for use in vitro diagnostic testing procedures; diagnostic apparatus and instruments for medical use, namely, for use in vitro diagnostic testing procedures and/or for use in measuring blood proteins, antibodies, enzymes, immunoglobulins, hormones and drugs; diagnostic imaging apparatus for medical use, namely, for use in vitro diagnostic testing procedures and/or for use in measuring blood proteins, antibodies, enzymes, immunoglobulins, hormones and drugs; clinical analyzers for medical and veterinary use, namely, for use in vitro diagnostic testing procedures and/or for use in measuring blood proteins, antibodies, enzymes, immunoglobulins, hormones and drugs; diagnostic testing apparatus and instruments for use in immunoassay procedures, namely, for use in the measurement of antibodies, immunoglobulins, hormones and drugs; detectors for use in vitro diagnostic testing procedures, namely, a chemiluminescence detection system; parts and fittings for all the aforesaid goods, namely, replacement parts and fittings

Diagnostic preparations and substances for medical and veterinary purposes; clinical chemistry and immunology test kits for medical purposes, consisting primarily of reagents for use in the detection and monitoring of disease states in vitro; clinical diagnostic preparations, for medical or veterinary use; clinical diagnostic reagents for in vivo use; diagnostic scanning agents for in vivo use; diagnostic testing materials for medical use in the detection and monitoring of disease states in vitro, namely, chemical reagents for the detection and monitoring of disease states including cardiac, DOA, stroke, metabolic, cancer, diabetes, fertility, thyroid and DNA arrays; medical diagnostic proteins, namely, antibodies and antigens used for medical detection of disease states in vitro

Diagnostic preparations for scientific purposes; chemical reagents for scientific or medical research and for use in the analysis of food products; enzymes for use in scientific and medical research applications; protein arrays for use in scientific and medical research applications; diagnostic preparations for analysis of food products and water; clinical diagnostic preparations for laboratory use; clinical diagnostic reagents for in vitro use; chemical reagents for detection and monitoring of disease states in vitro; diagnostic proteins, namely, antibodies and antigens used for monitoring of disease states in vitro

Filing History

CANCELLED SEC. 8 (6-YR)
Sep 30, 2016 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Feb 23, 2015 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 18, 2011 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 10, 2011 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 10, 2011 REAP
REGISTERED-PRINCIPAL REGISTER
Feb 23, 2010 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 8, 2009 NPUB
PUBLISHED FOR OPPOSITION
Dec 8, 2009 PUBO
LAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 30, 2009 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 29, 2009 CNSA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Oct 19, 2009 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Oct 17, 2009 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 8, 2009 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 8, 2009 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 8, 2009 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 8, 2009 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 8, 2009 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 8, 2009 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Oct 8, 2009 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Sep 18, 2009 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Sep 4, 2009 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 4, 2009 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 4, 2009 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 4, 2009 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 4, 2009 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 4, 2009 CNEA
AMENDMENT FROM APPLICANT ENTERED
Aug 12, 2009 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 12, 2009 CRFA
PAPER RECEIVED
Aug 10, 2009 MAIL
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jul 1, 2009 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jul 1, 2009 GNSI
SUSPENSION INQUIRY WRITTEN
Jul 1, 2009 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jun 11, 2009 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Dec 10, 2008 GNS3
LETTER OF SUSPENSION E-MAILED
Dec 10, 2008 GNSL
SUSPENSION LETTER WRITTEN
Dec 10, 2008 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 29, 2008 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 29, 2008 CRFA
ASSIGNED TO LIE
Oct 29, 2008 ALIE
PAPER RECEIVED
Oct 16, 2008 MAIL
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 15, 2008 GNRN
NON-FINAL ACTION E-MAILED
Apr 15, 2008 GNRT
NON-FINAL ACTION WRITTEN
Apr 15, 2008 CNRT
ASSIGNED TO EXAMINER
Mar 30, 2008 DOCK
NEW APPLICATION ENTERED
Jan 3, 2008 NWAP